C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2011
05/24/2011	US7947655 Methods for making proteins containing free cysteine residues
05/24/2011	US7947648 Methods for treating asthma in human and non human primates using IL-4 mutant compositions
05/24/2011	US7947496 Screening for cytotoxic end-points; cancerous disease modifying antibodies
05/24/2011	US7947481 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin
05/24/2011	US7947480 Everninomicin biosynthetic genes
05/24/2011	US7947479 Bardet-Biedl susceptibility gene and uses thereof
05/24/2011	US7947475 Modified variant Bowman Birk protease inhibitors
05/24/2011	US7947474 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment
05/24/2011	US7947471 Using transgenic cells as bioreactors for expression of heterologous polypeptides
05/24/2011	US7947470 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders
05/24/2011	US7947469 Protein comprising receptor nucleotide sequences associated with viral binding and/or infection for use in prevention and treatment of viral and autoimmune diseases; viricides
05/24/2011	US7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof
05/24/2011	US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses
05/24/2011	US7947286 Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain
05/24/2011	US7947274 Human cytomegalovirus neutralising antibodies and use thereof
05/24/2011	US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection
05/24/2011	CA2541651C Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
05/24/2011	CA2440596C Soluble heterodimeric cytokine receptor
05/24/2011	CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby
05/24/2011	CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
05/24/2011	CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum
05/24/2011	CA2270913C Human tumor necrosis factor receptor-like 2
05/24/2011	CA2266640C Methods for treating an ischemic disorder and improving stroke outcome
05/24/2011	CA2247067C Meltrins
05/24/2011	CA2211687C Vascular endothelial growth factor-b
05/24/2011	CA1341614C Targeted multifuncional proteins
05/19/2011	WO2011060233A1 Anti-tem1 antibodies and uses thereof
05/19/2011	WO2011060076A1 Anti-c-mpl antibodies
05/19/2011	WO2011059828A1 Methods of producing and purifying proteins
05/19/2011	WO2011059801A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	WO2011059684A1 Antibody glycosylation variants
05/19/2011	WO2011059478A1 Th1/th2 polarizing vaccines
05/19/2011	WO2011059092A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated
05/19/2011	WO2011057408A1 Protein concentrates and isolates, and processes for the production thereof
05/19/2011	WO2011057407A1 Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal
05/19/2011	WO2011057406A1 Protein concentrates and isolates, and processes for the production thereof from macroalgae and/or microalgae
05/19/2011	WO2006117782A3 Recombinant antibodies against cd55 and cd59 and uses thereof
05/19/2011	US20110119777 Use of aav replication machinery for improved protein production
05/19/2011	US20110118445 Inhibitor protein of the wnt signal pathway
05/19/2011	US20110118444 Binding molecules
05/19/2011	US20110118443 Antibody design using anti-lipid antibody crystal structures
05/19/2011	US20110118185 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
05/19/2011	US20110118183 N-glycosylated human growth hormone with prolonged circulatory half-life
05/19/2011	US20110118182 Process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
05/19/2011	US20110118177 Biotechnological production of cyanophycin dipeptides
05/19/2011	US20110117605 Methods for Manufacturing a Polyclonal Protein
05/19/2011	US20110117604 Copper-enriched biomass, method for the preparation thereof and pro-biotic , cosmetic, dietary and nutraceutic products comprising the same
05/19/2011	US20110117603 Enhancement of cellular production through mechanotransduction
05/19/2011	US20110117602 Human antibody capable of inducing apoptosis
05/19/2011	US20110117601 Glycosylation Profile Analysis
05/19/2011	US20110117600 Process for obtaining aspart insulin using a pichia pastoris yeast strain
05/19/2011	US20110117599 Artificial entropic bristle domain sequences and their use in recombinant protein production
05/19/2011	US20110117598 Enhanced Protein Production in Bacillus
05/19/2011	US20110117597 Enhancement of in vitro translation by nanoparticle conjugates
05/19/2011	US20110117131 Production of OspA for Lyme Disease Control
05/19/2011	US20110117117 Novel immunogenic epitopes for immunotherapy
05/19/2011	US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
05/19/2011	US20110117112 Sodium channel protein type iii alpha-subunit splice variant
05/19/2011	US20110117110 Anti-egfr antibodies and their uses
05/19/2011	US20110117087 Method for the production of a glycosylated immunoglobulin
05/19/2011	US20110117086 Monoclonal antibodies to progastrin and their uses
05/19/2011	US20110117080 Anti-REG4 Antibodies
05/19/2011	US20110117079 Therapeutic dll4 binding proteins
05/19/2011	CA2801536A1 Protein concentrates and isolates, and processes for the production thereof from macroalgae and/or microalgae
05/19/2011	CA2781045A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated
05/19/2011	CA2780763A1 Factor viii b cell epitope variants having reduced immunogenicity
05/19/2011	CA2780761A1 Factor viii t cell epitope variants having reduced immunogenicity
05/19/2011	CA2780583A1 Protein concentrates and isolates, and processes for the production thereof
05/19/2011	CA2780579A1 Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal
05/19/2011	CA2779683A1 Anti-c-mpl antibodies
05/19/2011	CA2779293A1 Solution assay and high through-put screen to probe interaction between human cullin-ring ligase complex and hiv-vif protein
05/19/2011	CA2778839A1 Glycosyl transferase from chinese hamster and related methods
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322644A1 Methods for producing modified glycoproteins
05/18/2011	EP2322636A1 Alpha galactosidase attached to an ER retention signal and its production in plants
05/18/2011	EP2322631A1 In vivo incorporation of unnatural amino acids
05/18/2011	EP2322625A1 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
05/18/2011	EP2322610A1 Anti-human clcp1 antibody and use thereof
05/18/2011	EP2322562A1 Monoclonal antibody, and immunoassay using same
05/18/2011	EP2322539A2 A method for identification, isolation and production of antigens to a specific pathogen
05/18/2011	EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011	EP2322221A1 Pharmaceutical composition for treatment and prevention of cancer
05/18/2011	EP2322216A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
05/18/2011	EP2322209A2 Tumor specific oligosaccharide epitopes and use thereof
05/18/2011	EP2322203A2 Compositions and methods for the treatment of immune related diseases
05/18/2011	EP2322202A2 Compositions and methods for the treatment of immune diseases
05/18/2011	EP2322201A2 Compositions and methods for the treatment of immune related diseases
05/18/2011	EP2322200A2 Compositions and methods for the treatment of immune related diseases
05/18/2011	EP2322191A2 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same
05/18/2011	EP2322165A1 Apo2 ligand/TRAIL formulations
05/18/2011	EP2321422A2 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
05/18/2011	EP2321356A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
05/18/2011	EP2320751A2 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
05/18/2011	EP1673457B1 Novel fungal proteins and nucleic acids encoding same
05/18/2011	EP1478764B1 Humanized collagen antibodies and related methods
05/18/2011	EP1451325B1 Transcription factor stress-related polypeptides and methods of use in plants
05/18/2011	EP1370674B1 Enzymes having alpha amylase activity and methods of use thereof
05/18/2011	EP1356298B1 Diagnosis of disease
05/18/2011	CN1961067B Method for culturing the nitrile hydratase-producing strain rodococcus rhodochrous M33
05/18/2011	CN1425068B Fungal transcriptional activator useful in methods for producing polypeptides

1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1125